Lipid Metabolism — MCQs

Lipid Metabolism Indian Medical PG Practice Questions and MCQs

Question 691: Which protein hormone is often referred to as the 'guardian angel against obesity' due to its role in regulating metabolism?

A. Adiponectin (Correct Answer)
B. Fibronectin
C. High-Density Lipoprotein (HDL)
D. Insulin

Explanation: ***Adiponectin*** - **Adiponectin** is a hormone secreted by **adipose tissue** that plays a crucial role in regulating glucose and fatty acid metabolism, increasing **insulin sensitivity**, and decreasing inflammation. - Its levels are inversely correlated with body fat percentage; individuals with obesity tend to have lower adiponectin levels, leading to its nickname as the 'guardian angel against obesity'. *Fibronectin* - **Fibronectin** is a glycoprotein involved in cell adhesion, growth, migration, and differentiation, and is a key component of the **extracellular matrix**. - It does not primarily function in metabolic regulation or body weight control, unlike adiponectin. *High-Density Lipoprotein (HDL)* - **HDL** is a type of lipoprotein that transports cholesterol from peripheral tissues back to the liver, a process known as **reverse cholesterol transport**. - While beneficial for cardiovascular health, HDL is a lipid-carrying particle, not a protein hormone, and its primary role is not in metabolic regulation or direct obesity prevention. *Insulin* - **Insulin** is a peptide hormone produced by the pancreas that regulates carbohydrate and fat metabolism, primarily by facilitating glucose uptake from the blood into cells. - While essential for metabolism, high levels of insulin in the context of insulin resistance can contribute to obesity, rather than act against it.

Question 692: Krabbe's disease is due to deficiency of ?

A. Sphingomyelinase
B. Beta galactocerebrosidase (Correct Answer)
C. Hexosaminidase
D. Arylsulfatase

Explanation: ***Beta galactocerebrosidase*** - Krabbe's disease is specifically caused by a deficiency of **beta-galactocerebrosidase**, leading to the accumulation of toxic substances in the brain [1]. - This disease predominantly affects the **myelin sheath**, resulting in severe neurological deterioration [1]. *Arylsulfatase* - Deficiency of **arylsulfatase** is associated with **metachromatic leukodystrophy**, not Krabbe's disease. - Symptoms and pathology differ significantly, primarily affecting **sulfatides** rather than galactocerebrosides. *Sphingomyelinase* - A deficiency of **sphingomyelinase** is linked to **Niemann-Pick disease**, characterized by splenomegaly and liver involvement. - This condition does not involve the same neurological deterioration seen in Krabbe's disease. *Hexosaminidase* - Hexosaminidase deficiency is associated with **Tay-Sachs disease**, primarily affecting the **GM2 gangliosides** [2]. - This results in different clinical manifestations, such as **cherry-red spots** and progressive neurodegeneration, rather than the symptoms of Krabbe's disease [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1304-1305. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 161.

Question 693: Which of the following statements about LDL is false?

A. More dense than chylomicron
B. Transports maximum amount of lipid (Correct Answer)
C. Contains maximum cholesterol
D. Smaller than VLDL

Explanation: ***Transports maximum amount of lipid*** - This statement is false because **chylomicrons**, not LDL, are primarily responsible for transporting the **maximum amount of dietary lipids** (triglycerides) from the intestines to various tissues. - While LDL does transport lipids, its primary role is to deliver **cholesterol** to cells, and it contains a lower proportion of triglyceride compared to chylomicrons and VLDL. *More dense than chylomicron* - This statement is true; **LDL is denser than chylomicrons** because it has a higher protein-to-lipid ratio. - **Chylomicrons** are the least dense lipoproteins due to their very high triglyceride content. *Smaller than VLDL* - This statement is true; **LDL is smaller than VLDL** (Very Low-Density Lipoprotein). - VLDL particles are larger and contain more triglycerides, which are gradually removed, leading to the formation of smaller LDL particles. *Contains maximum cholesterol* - This statement is true; **LDL contains the highest proportion of cholesterol** (specifically, **cholesterol esters**) among the lipoproteins. - This characteristic makes LDL the primary carrier for delivering cholesterol to peripheral tissues.

Question 694: Which of the following is not a phospholipid ?

A. Lecithin
B. Plasmalogen
C. Cardiolipin
D. Ganglioside (Correct Answer)

Explanation: ***Ganglioside*** - Gangliosides are a type of **glycosphingolipid** because their structure includes a ceramide (a sphingoid base linked to a fatty acid) and a carbohydrate portion with one or more **sialic acid** residues, but no phosphate group. - They are primarily found in **nerve cell membranes** and are crucial for cell-cell recognition and signaling, differentiating them from phospholipids which contain a phosphate group. *Lecithin* - Lecithin, specifically **phosphatidylcholine**, is a common phospholipid characterized by a **phosphate group** and a **choline head group** attached to a diacylglycerol backbone. - It plays vital roles in cell membrane structure and function and is an important emulsifier. *Plasmalogen* - Plasmalogens are a class of phospholipids characterized by a **vinyl ether linkage** at the *sn*-1 position of the glycerol backbone, instead of the typical ester linkage found in other phospholipids. - They retain the defining **phosphate group** that classifies them as phospholipids. *Cardiolipin* - Cardiolipin is a unique phospholipid composed of **two phosphatidic acid moieties** connected by a glycerol molecule, resulting in four fatty acid chains and two phosphate groups. - It is predominantly found in the **inner mitochondrial membrane**, essential for mitochondrial function.

Question 695: Which of the following statements about ketone bodies is false?

A. Synthesized in mitochondria
B. Synthesized in liver
C. HMG CoA reductase is the rate-limiting enzyme (Correct Answer)
D. Acetoacetate is primary ketone body

Explanation: ***HMG CoA reductase is the rate-limiting enzyme*** - This statement is **false** because **HMG-CoA synthase**, not HMG-CoA reductase, is the **rate-limiting enzyme in ketogenesis**. - **HMG-CoA reductase** is the rate-limiting enzyme in **cholesterol synthesis**, a completely different metabolic pathway. *Acetoacetate is primary ketone body* - **Acetoacetate** is indeed considered the **primary ketone body**, as **β-hydroxybutyrate** is derived from it and **acetone** is a spontaneous breakdown product of acetoacetate. - It is the first ketone body formed during the synthesis pathway. *Synthesized in mitochondria* - Ketone bodies are synthesized in the **mitochondrial matrix** of liver cells. - This location allows for the efficient use of **acetyl-CoA** generated from fatty acid oxidation. *Synthesized in liver* - The liver is the **primary site of ketogenesis**, where fatty acids are converted into ketone bodies. - This process is crucial for providing alternative fuel to extrahepatic tissues during periods of fasting or prolonged starvation.

Question 696: Concentration of which is inversely related to the risk of coronary heart disease?

A. VLDL
B. LDL
C. HDL (Correct Answer)
D. None of the options

Explanation: ***HDL*** - **High-density lipoprotein (HDL)** is known as "good cholesterol" because it helps remove excess cholesterol from the arteries and transport it back to the liver for excretion. - Higher levels of HDL are generally associated with a **lower risk of coronary heart disease (CHD)**, hence the inverse relationship. *VLDL* - **Very low-density lipoprotein (VLDL)** carries triglycerides and cholesterol and is considered an independent risk factor for CHD when present in high concentrations. - High VLDL levels are associated with an **increased risk of CHD**, not an inverse relationship. *LDL* - **Low-density lipoprotein (LDL)** is often referred to as "bad cholesterol" because it contributes to plaque buildup in arteries (**atherosclerosis**). - High levels of LDL are strongly associated with an **increased risk of CHD**, indicating a direct, not inverse, relationship. *None of the options* - This option is incorrect because HDL clearly demonstrates an **inverse relationship** with the risk of coronary heart disease.

Question 697: What is essential for the transfer of fatty acid across the mitochondrial membrane?

A. Creatinine
B. Carnitine (Correct Answer)
C. Biotin
D. Creatine

Explanation: ***Carnitine*** - **Carnitine** is crucial for transporting **long-chain fatty acids** into the mitochondrial matrix for **beta-oxidation**. - It forms **acylcarnitine** by esterifying with fatty acids, allowing passage through the inner mitochondrial membrane via the **carnitine-acylcarnitine translocase**. *Creatinine* - **Creatinine** is a waste product formed from the breakdown of **creatine phosphate** in muscles and is excreted by the kidneys. - It serves as a marker for **kidney function** and has no role in fatty acid transport. *Biotin* - **Biotin** is a vitamin cofactor essential for **carboxylase enzymes**, including acetyl-CoA carboxylase in **fatty acid synthesis**. - While involved in lipid metabolism, it plays no role in the transport of fatty acids across mitochondrial membranes. *Creatine* - **Creatine** is a nitrogenous organic acid that helps supply energy to cells, primarily muscle, by facilitating the regeneration of **ATP**. - It plays no direct role in the facilitated transport of fatty acids across the mitochondrial membrane.

Question 698: Which of the following is not an androgen?

A. 17α-hydroxyprogesterone (Correct Answer)
B. Testosterone
C. Dihydrotestosterone
D. Androstenedione

Explanation: ***17α-hydroxyprogesterone*** - This is a **progesterone derivative** and an intermediate in the synthesis of androgens and corticosteroids, but it does **not possess significant androgenic activity** itself. - Its primary role is as a precursor, rather than a direct androgen. *Testosterone* - **Testosterone** is the **primary male sex hormone** and a potent androgen, responsible for the development of male secondary sexual characteristics. - It plays crucial roles in muscle mass, bone density, libido, and erythropoiesis. *Dihydrotestosterone* - **Dihydrotestosterone (DHT)** is a potent androgen, formed from testosterone by the enzyme 5α-reductase. - DHT is responsible for the development of external male genitalia during fetal development and contributes to prostate growth and male pattern baldness in adults. *Androstenedione* - **Androstenedione** is a **weak androgen** and an important **precursor hormone** in the biosynthesis of testosterone and estrogens. - It is produced in the adrenal glands and gonads, serving as an intermediate step in steroidogenesis.

Question 699: Which of the following lipoproteins is most strongly associated with an increased risk of cardiovascular diseases and is commonly referred to as "bad cholesterol"?

A. VLDL
B. Chylomicron
C. Lp (a)
D. LDL (Correct Answer)

Explanation: ***LDL*** - **Low-density lipoprotein (LDL)** is commonly referred to as "bad" cholesterol because elevated levels are the **primary driver** of atherosclerotic plaque buildup in arterial walls. - LDL particles transport cholesterol from the liver to peripheral tissues; when present in excess, they infiltrate the arterial intima and undergo oxidative modification, triggering inflammatory responses that lead to atherosclerosis. - **Clinical significance:** LDL cholesterol is the primary target of lipid-lowering therapy in cardiovascular disease prevention. *VLDL* - **Very low-density lipoprotein (VLDL)** primarily transports endogenously synthesized **triglycerides** from the liver to peripheral tissues. - While elevated VLDL levels do contribute to cardiovascular risk (particularly through conversion to small, dense LDL particles), it is not the primary lipoprotein targeted in cardiovascular risk assessment. *Chylomicron* - **Chylomicrons** transport **dietary lipids** (triglycerides and cholesterol) from the intestines to tissues after meals. - They are rapidly cleared from circulation (half-life of 5-10 minutes) and are typically not present during fasting, making their contribution to chronic atherosclerotic plaque formation minimal. *Lp(a)* - **Lipoprotein(a) [Lp(a)]** is structurally similar to LDL but contains an additional apolipoprotein(a) molecule, which has homology to plasminogen and may interfere with fibrinolysis. - While Lp(a) is an independent cardiovascular risk factor, it is less commonly measured in routine clinical practice, and **LDL remains the cornerstone lipoprotein** for cardiovascular risk stratification and management.

Question 700: Which is the first steroid intermediate formed in the conversion of cholesterol to steroid hormones?

A. Glucocorticoid
B. Mineralocorticoid
C. Estradiol
D. Pregnenolone (Correct Answer)

Explanation: ***Pregnenolone*** - **Pregnenolone** is the **first steroid intermediate** formed from **cholesterol** in steroidogenesis - The conversion occurs in mitochondria via the **cholesterol side-chain cleavage enzyme (P450scc/CYP11A1)** - This is the **rate-limiting step** in steroid hormone biosynthesis - From pregnenolone, all other steroid hormones are subsequently synthesized *Progesterone* - Progesterone is the **second intermediate**, formed from pregnenolone - It serves as a precursor for glucocorticoids, mineralocorticoids, and androgens - Not the first intermediate from cholesterol *Glucocorticoid* - Glucocorticoids (e.g., cortisol) are **end products**, not intermediates - Formed several steps downstream from cholesterol via pregnenolone and progesterone *Mineralocorticoid* - Mineralocorticoids (e.g., aldosterone) are **end products**, not intermediates - Synthesized from progesterone through multiple enzymatic steps *Estradiol* - Estradiol is a **late-stage product** synthesized from androgens - Requires aromatase enzyme for conversion from testosterone - Multiple steps removed from the initial cholesterol conversion

Practice by Chapter

Lipid Classification and Chemistry

Practice Questions

Fatty Acid Oxidation

Practice Questions

Ketone Body Metabolism

Practice Questions

Fatty Acid Synthesis

Practice Questions

Metabolism of Triacylglycerols

Practice Questions

Phospholipid Metabolism

Practice Questions

Cholesterol Metabolism and Biosynthesis

Practice Questions

Bile Acids and Bile Salts

Practice Questions

Lipoprotein Metabolism and Transport

Practice Questions

Dyslipidemias and Atherosclerosis

Practice Questions

Prostaglandins and Eicosanoids

Practice Questions

Fatty Liver and Lipotropic Factors

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free